0. SOLD. Biotech "A state of the art biologics facility in the UK:  EMEA approved and FDA compliant biologics facility undertaking contract manufacturing, undergoing debt restructuring."

1. Blood Plasma products. "A foreign pharma company is exploring biz options for India and will be pleased to be introduced through our network with potential partners that would be able to represent and/or distribute their immunoglobulin and other products. i.e. blood plasma products for critical care situations. The products are licensed and marketed in the local market and in at least twenty other countries across the world." 

2.Tie ups & Registrations Australia. "Pls send us company profile and their objectives for Australia and we will revert after scouting Aust pharma sector thru the top Aust. pharma law firm. You may take a mandate from companies to accomplish their objectives in Australia."

3. Diabetes. "Please look for companies that have any specific interest in diabetes. Together with our UK counterparts, we may get a mandate that may make some new products available."

4. Distribution & Registration UK  "A 40 million UKP plus UK wholesaler with over 30 retail outlets are looking for Indian pharma cos producing generics for arranging 'import & distribute' tie ups. They also have the ability to get products regtd & licensed for such purpose in the UK. All information is available based on an NDA cum success fee mandate. "

5. Antibody D Technology "Our UK counterparts are in a position to facilitate license of an antibody platform from a leading foreign company which can become the nucleus of an antibody contract manufacturing enterprise. The platform has been used to develop some of the 1000 million dollar drugs on the market."

6. Distribution pharma/ OTC products " Introduction to a leading UK based distributor, financed by a  pvt. equity major, with operations in many countries in Europe, Africa & East Asia is possible. The co. aims to service a much broader segment of the pharmaceutical and healthcare markets than many similarly sized pharmaceutical companies. It sells ethical (prescription) pharmaceuticals, non-prescription medicines, vitamins, minerals and supplements and a wide range of other healthcare products."

7.  Trade: Africa, Middle East & South Asia" Any trade inquiries maybe sent to a former sr. export personnel of one of India's leading Pharmaceutical companies in the business."

8.  Acquisition/ jv's for manufacturing India/Gujarat " An inquiry for j.v./ acquisition of Indian pharmaceutical companies has been received from a company in UK. "  

9. Hepatitis B Technology/Distribution " Any Group willing take up a Rs 20 Cr project can consider Licensed manufacturing of  Hepatitis  B Vaccine.  Also , the principal has one running unit for which he wants  to market Territory rights for Gujarat. Any takers?"

 10. Cold Chain: "A leading Japanese trading company is setting up a j.v. Its activities will include manufacturing the refrigeration containers in the region and developing a distribution network in the whole of South Asia and a portion of Middle East. Inquiries?" 

11.  Private equity: " Indian Pharma/biotech co's deal size i) $3-7 mill/ii)>$ 7 mill." 

12a. Proj. Financing : "A leading multilateral agency can arrange financing in emerging markets in the Healthcare & Education sector. min$5 million, max 25% of project cost." 

12b. Bank finance, Gujarat:  "A leading public sector bank can arrange rupee financing (as a consortium leader) or letter of comforts for exposure to ECBs'. min 25 crs. or more."

12c. Acquisition finance Developed Markets :  " Inquires can be fwd. to leading  NBFC's/banks  with presence in India and headquartered abroad."

13. Political Risk Insurance: "A leading multilateral agency can give any kind of Political risk insurance in emerging markets for  FDI projects for equity plus debt coverage."

14. International Networking: "Advertise your specific requirements on a web based platform created by the World Bank or access an international network of  Investment Promotion Agency’s/Commercial consulates/ pharma focused investment bankers."

Kindly revert back with your interest & one can proceed on a case to case basis  after  completing the  paperwork. Please do not hesitate to get in touch for any assistance.  Sincerely,

Siddharth Kohli
Managing Partner
                                                                 
India Development & Environment Agency,
IDEA, a new investment promotion initiative
A 1/8, Tirthjal, Satellite Ring Road,
Ahmedabad, 380 015.
Tel: ( 079)  2673 0005 (dir)  Fax ( 079) 2630 9801
website www.ideagujarat.com
 email idea@icenet.net
Mobile 98240 17302

Content Partners:
Ajay Jugran, Managing Partner,  LAWCOMBINE, Advocates
& Hony. Legal Counsel / Advisor, IDEA
 
Mobile / Cell:+91 98 110 171 39
E-mail: a_jugran@lawcombine.com

LAWCOMBINE Advocates

Gurgaon Office:
L-3 / 33 A, DLF - II, Gurgaon
Haryana - 122002, INDIA
Tel: +91 124 50 176 74 & 75 (Fm Del 95 176 74 & 75)
Fax: +91 124 50 103 33 (Fm Del 95124-50 103 33)
http://www.lawcombine.com

Legal disclaimer:  IDEA and its content partners disclaim / do not accept any liability whastsoever for any information contained herein and or any party's acts and or omissions in reliance thereupon or in pursuance thereof. Any and all information released in this newsletter is free of cost and shall not bind IDEA and its content partners to any one or anything in any manner whatsoever.